FDA May Reconsider SPF 30+ Sunscreen Labeling Requirement
This article was originally published in The Tan Sheet
Executive Summary
FDA may be willing to reconsider the sunscreen final monograph requirement that sunscreen products with SPFs over 30 may only state they are "30 plus," Office of Drug Evaluation V Director Robert DeLap, MD/PhD, said at an OTC "feedback" meeting on the reg in Rockville, Md. July 22. "We haven't closed any doors in a permanent sense" regarding the provision, DeLap told attendees.